Concepedia

DM Hyman

DH

Statistics

Publications

2

Citations

169

H-Index

2

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

Vall d'Hebron Hospital Universitari

Memorial Sloan Kettering Cancer Center

DM Hyman is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2016–2019

2

Publications

2

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Rosaria Condorelli, Fernanda Mosele, B. Verret et al. · Annals of Oncology · 2019 · 154 citations · Full text

, , +16

Abstract PD5-05: Neratinib for <i>ERBB2</i> mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial

DM Hyman, SA Piha-Paul, Jordi Rodón et al. · Cancer Research · 2016 · 15 citations

, , +17

1–2 of 2